Clinical Trial Update: A Study of Oxidative Pathways in MS Fatigue [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluated oxidative pathways related to fatigue in progressive multiple sclerosis, with results posted in February 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Snippet

Sponsor: University of California, San Francisco | Conditions: Progressive Multiple Sclerosis, Fatigue | Phase 2 | Status: COMPLETED | Results posted: 2020-02-18